DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

9.88 0.84 (9.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

HALO $9.88 9.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.26
Previous Close $9.04
Daily Range $9.24 - $9.90
52-Week Range $6.88 - $18.18
Market Cap $1.2B
P/E Ratio -12.73
Dividend (Yield) $0.00 (0.0%)
Volume 2,968,010
Average Daily Volume 1,156,076
Current FY EPS -$0.67

Sector

Healthcare

Industry

Drugs

Halozyme Therapeutics, Inc. (HALO) Description

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets. Website: http://www.halozyme.com/

News & Commentary Rss Feed

2 Small-Cap Stocks Hedge Funds Love

See if either stock makes sense for your portfolio.

5 Stocks With Big Insider Buying

Recent Price Decline Creates An Attractive Entry Point For Halozyme

Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog

Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog

Sector Update: Health Care Stocks Mixed; Baxter International, Halo Therapeutics Declining Despite R

Sector Update: Health Care Stocks Mixed; Baxter International, Halo Therapeutics Declining Despite Regulatory OKs for Hemophilia Drug

Sector Update: Health Care

Halozyme Is Worth Betting On

Morning Market Movers

Benzinga's Top #PreMarket Gainers

Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock - Tale of the Tape

Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog

See More HALO News...

HALO's Top Competitors

HALO $9.88 (9.29%)
Current stock: HALO
AMGN $140.71 (0.99%)
Current stock: AMGN
GILD $103.84 (-0.88%)
Current stock: GILD
BIIB $327.58 (0.21%)
Current stock: BIIB